Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / COLL - Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday


COLL - Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday

At times, the reason or reasons behind a stock's rise are obscure or mysterious. But that certainly wasn't the case with Collegium Pharmaceutical (NASDAQ: COLL) on Tuesday, which shot 9.8% higher thanks to a development that should dramatically raise its profile.

Collegium, a biotech that has enjoyed success with its pain relief medication Xtampza ER , is about to become a component of the S&P stock index family.

Late Monday, S&P Dow Jones Indices -- the operator of the famous suite of indexes -- announced a change in its benchmark S&P 500 index.

Continue reading

For further details see:

Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday
Stock Information

Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com

Menu

COLL COLL Quote COLL Short COLL News COLL Articles COLL Message Board
Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...